Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 152

1.

Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3.

Currier JS, Britto P, Hoffman RM, Brummel S, Masheto G, Joao E, Santos B, Aurpibul L, Losso M, Pierre MF, Weinberg A, Gnanashanmugam D, Chakhtoura N, Klingman K, Browning R, Coletti A, Mofenson L, Shapiro D, Pilotto J; 1077HS PROMISE Team.

PLoS One. 2017 May 10;12(5):e0176009. doi: 10.1371/journal.pone.0176009. eCollection 2017.

2.

Factors associated with retention in Option B+ in Malawi: a case control study.

Hoffman RM, Phiri K, Parent J, Grotts J, Elashoff D, Kawale P, Yeatman S, Currier JS, Schooley A.

J Int AIDS Soc. 2017 Apr 27;20(1):1-8. doi: 10.7448/IAS.20.01.21464.

3.

Oxidation state specific analysis of arsenic species in tissues of wild-type and arsenic (+3 oxidation state) methyltransferase-knockout mice.

Currier JM, Douillet C, Drobná Z, Stýblo M.

J Environ Sci (China). 2016 Nov;49:104-112. doi: 10.1016/j.jes.2016.06.018. Epub 2016 Jul 18.

4.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM; IMPAACT 1077BF/1077FF PROMISE Study Team.

N Engl J Med. 2016 Nov 3;375(18):1726-1737.

5.

Reimann's "Habitual Hyperthermia" Responding to Hormone Therapy.

Yang OO, Currier JS.

Open Forum Infect Dis. 2016 Jul 26;3(3):ofw127. eCollection 2016 Sep.

6.

A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?

Lederman MM, Cannon PM, Currier JS, June CH, Kiem HP, Kuritzkes DR, Lewin SR, Margolis DM, McCune JM, Mellors JW, Schacker TW, Sekaly RP, Tebas P, Walker BD, Douek DC.

Pathog Immun. 2016 Spring;1(1):154-164.

7.

Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s.

Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA.

Open Forum Infect Dis. 2016 Aug 29;3(3):ofw174. eCollection 2016 Sep.

8.

Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study.

Diaz CM, Segura ER, Luz PM, Clark JL, Ribeiro SR, De Boni R, Eksterman L, Moreira R, Currier JS, Veloso VG, Grinsztejn B, Lake JE.

BMC Infect Dis. 2016 Aug 8;16:376. doi: 10.1186/s12879-016-1735-4.

9.

Developing a Gene Biomarker at the Tipping Point of Adaptive and Adverse Responses in Human Bronchial Epithelial Cells.

Currier JM, Cheng WY, Menendez D, Conolly R, Chorley BN.

PLoS One. 2016 May 19;11(5):e0155875. doi: 10.1371/journal.pone.0155875. eCollection 2016.

10.

HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative.

Hanna DB, Guo M, Bůžková P, Miller TL, Post WS, Stein JH, Currier JS, Kronmal RA, Freiberg MS, Bennett SN, Shikuma CM, Anastos K, Li Y, Tracy RP, Hodis HN, Delaney JA, Kaplan RC.

Clin Infect Dis. 2016 Jul 15;63(2):249-56. doi: 10.1093/cid/ciw261. Epub 2016 Apr 26.

11.

Supporting Treatment Adherence Readiness through Training (START) for patients with HIV on antiretroviral therapy: study protocol for a randomized controlled trial.

Wagner GJ, Linnemayr S, Ghosh-Dastidar B, Currier JS, Hoffman R, Schneider S.

Trials. 2016 Mar 24;17:162. doi: 10.1186/s13063-016-1287-3.

12.

Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s.

McComsey GA, Moser C, Currier J, Ribaudo HJ, Paczuski P, Dubé MP, Kelesidis T, Rothenberg J, Stein JH, Brown TT.

Clin Infect Dis. 2016 Apr 1;62(7):853-62. doi: 10.1093/cid/ciw017. Epub 2016 Jan 20.

13.

Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV.

Looby SE, Fitch KV, Srinivasa S, Lo J, Rafferty D, Martin A, Currier JC, Grinspoon S, Zanni MV.

AIDS. 2016 Jan 28;30(3):383-93. doi: 10.1097/QAD.0000000000000902.

14.

Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.

Hoffman RM, Lake JE, Wilhalme HM, Tseng CH, Currier JS.

AIDS Res Hum Retroviruses. 2016 Mar;32(3):247-54. doi: 10.1089/aid.2015.0200. Epub 2015 Nov 16.

15.

Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.

Cillo AR, Hilldorfer BB, Lalama CM, McKinnon JE, Coombs RW, Tenorio AR, Fox L, Gandhi RT, Ribaudo H, Currier JS, Gulick RM, Wilkin TJ, Mellors JW.

AIDS. 2015 Oct 23;29(16):2121-9. doi: 10.1097/QAD.0000000000000810.

16.

Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity.

Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Currier JS.

Open Forum Infect Dis. 2015 Apr 26;2(2):ofv059. doi: 10.1093/ofid/ofv059. eCollection 2015 Apr.

17.

A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.

Stein JH, Ribaudo HJ, Hodis HN, Brown TT, Tran TT, Yan M, Brodell EL, Kelesidis T, McComsey GA, Dube MP, Murphy RL, Currier JS.

AIDS. 2015 Sep 10;29(14):1775-83. doi: 10.1097/QAD.0000000000000762. Erratum in: AIDS. 2016 Jan;30(2):337.

18.

Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study.

Lake JE, Seang S, Kelesidis T, Liao DH, Hodis HN, Stein JH, Currier JS.

HIV Clin Trials. 2015 Oct;16(5):197-206. doi: 10.1179/1945577115Y.0000000006. Epub 2015 Sep 11.

19.

Suicidal behavior and spiritual functioning in a sample of Veterans diagnosed with PTSD.

Kopacz MS, Currier JM, Drescher KD, Pigeon WR.

J Inj Violence Res. 2016 Jan;8(1):6-14. doi: 10.5249/jivr.v8i1.728. Epub 2015 Sep 10.

20.

Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.

Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, Currier JS, Grinsztejn B, Lake JE.

Nutr J. 2015 Aug 18;14:81. doi: 10.1186/s12937-015-0072-6.

Supplemental Content

Loading ...
Support Center